Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MN Providers

Dr. Paul Harvey Waytz, MD

(13 Ratings)

Specializes in: Adult Rheumatology

7600 France Avenue S Suite 5100
Edina, MN 55435

(952) 893-1959

Dr. Paul Harvey Waytz, MD is a rheumatologist in Edina, MN specializing in adult rheumatology.

Office Locations

7600 France Avenue S Suite 5100
Edina, MN 55435

(952) 893-1959

(952) 893-1954

open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Paul Harvey Waytz, MD treated as a rheumatologist in Edina, MN during 2012 were lab tests, blood draw, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Paul Harvey Waytz, MD for Medicare patients.

biological response modifier (BRM) therapy	129
blood draw	283
chemotherapy	129
doctor visit	543
lab tests	1282
minimally invasive procedures	129
musculoskeletal imaging	17
X-rays	17

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Paul Harvey Waytz, MD treated as a rheumatologist in Edina, MN during 2013 were lab tests, blood draw, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Paul Harvey Waytz, MD for Medicare patients.

biological response modifier (BRM) therapy	138
blood draw	236
chemotherapy	138
doctor visit	515
lab tests	1148
minimally invasive procedures	138
musculoskeletal imaging	24
X-rays	24

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul Harvey Waytz, MD.

**Gender**
Male	87
Female	214

**Age**
From 65 to 74	132
From 75 to 84	106
85 and over	32
Less than 65	31

Conditions of Medicare patients treated by Dr. Paul Harvey Waytz, MD in 2013

Hypertension	48
High Cholesterol	37
Stroke	4
Ischemic Heart Disease	23
Depression	22
Chronic Kidney Disease	16
Asthma	7
Osteoperosis	17
Atrial Fibrilation	8
Heart Failure	8
Chronic Obstructive Pulmonary Disease	6
Diabetes	15
Dementia	5
Cancer	11

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Paul Harvey Waytz, MD treated as a rheumatologist in Edina, MN during 2014 were lab tests, blood draw, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Paul Harvey Waytz, MD for Medicare patients.

biological response modifier (BRM) therapy	105
blood draw	192
chemotherapy	105
doctor visit	443
lab tests	968
minimally invasive procedures	105

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul Harvey Waytz, MD.

**Gender**
Male	68
Female	188

**Age**
From 65 to 74	122
From 75 to 84	76
85 and over	28
Less than 65	30

Conditions of Medicare patients treated by Dr. Paul Harvey Waytz, MD in 2014

Hypertension	48
High Cholesterol	34
Stroke	0
Ischemic Heart Disease	23
Depression	21
Chronic Kidney Disease	15
Asthma	7
Osteoperosis	18
Atrial Fibrilation	11
Heart Failure	8
Chronic Obstructive Pulmonary Disease	5
Diabetes	16
Dementia	4
Cancer	9

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2014

Volume of procedures performed by Dr. Paul Harvey Waytz, MD for Medicare patients.

The highest averages for the top procedures that Dr. Paul Harvey Waytz, MD treated as a rheumatologist in Edina, MN were lab tests, blood draw, chemotherapy and biological response modifier (BRM) therapy.

biological response modifier (BRM) therapy	124
blood draw	237
chemotherapy	124
doctor visit	500
lab tests	1132
minimally invasive procedures	124
musculoskeletal imaging	20
X-rays	20

Average Medicare Patient Data From 2012 - 2014

Information about Medicare patients treated by Dr. Paul Harvey Waytz, MD.

**Gender**
Female	134
Male	51

**Age**
85 and over	20
75 to 84	60
Less than 65	20
65 to 74	84

Average of Total of Conditions of Medicare patients treated by Dr. Paul Harvey Waytz, MD From 2012 - 2014

The highest averages of the most common conditions of Medicare patients that Dr. Paul Harvey Waytz, MD treated were hypertension, high cholesterol, depression and ischemic heart disease.

Hypertension	32
High Cholesterol	23
Stroke	1
Ischemic Heart Disease	15
Depression	14
Chronic Kidney Disease	10
Asthma	4
Osteoporosis	11
Heart Failure	5
Chronic Obstructive Pulmonary Disease	3
Diabetes	10
Atrial Fibrillation	6
Dementia	3
Cancer	6

Education & Training

He has a state license in Minnesota.

Licensed In: Minnesota

Ratings & Reviews

Dr. Paul Harvey Waytz, MD has a high overall rating with an average of 4.31 out of 5 stars based on 13 ratings. We collect ratings and reviews of Dr. Paul Harvey Waytz, MD from all over the web to help you find the right in Edina, MN.

4.31

Overall Rating

(13 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Paul Harvey Waytz, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Hexal AG	$356 $356
Celgene Corporation	$24 Otezla $24
Crealta Pharmaceuticals LLC	$16 KRYSTEXXA $16
Takeda Pharmaceuticals America, Inc.	$14 Colcrys $14
GlaxoSmithKline, LLC.	$12 BENLYSTA $12

**Types of Payments**
Food and Beverage	$263
Travel and Lodging	$160

Research Payments

Dr. Paul Harvey Waytz, MD has received 81 research payments totaling $139,793.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Paul Harvey Waytz, MD.

Vertebral Technologies, Inc.	2013	$2,254.40	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2016	$2,254.40	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2015	$1,916.24	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2014	$1,916.24	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2017	$56.36	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2018	$56.36	Physician Covered Recipient	stock ownership
Vertebral Technologies, Inc.	2020	$0.00	Physician Covered Recipient	Stock ownership
Vertebral Technologies, Inc.	2019	$0.00	Physician Covered Recipient	Stock ownership